Cargando…
Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy
Hepatocellular carcinoma (HCC) is a common malignant tumor that affecting many people's lives globally. The common risk factors for HCC include being overweight and obese. The liver is the center of lipid metabolism, synthesizing most cholesterol and fatty acids. Abnormal lipid metabolism is a...
Autores principales: | Feng, Xiao-Chen, Liu, Fu-Chen, Chen, Wu-Yu, Du, Jin, Liu, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134209/ https://www.ncbi.nlm.nih.gov/pubmed/37123054 http://dx.doi.org/10.4251/wjgo.v15.i4.617 |
Ejemplares similares
-
Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma
por: Contratto, Merly, et al.
Publicado: (2018) -
Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
por: Xie, Shuqi, et al.
Publicado: (2023) -
Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma
por: Laface, Carmelo, et al.
Publicado: (2023) -
Unveiling the Role of Tumor-Infiltrating T Cells and Immunotherapy in Hepatocellular Carcinoma: A Comprehensive Review
por: Chen, Xiaokun, et al.
Publicado: (2023) -
Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma
por: Dai, Xiaomeng, et al.
Publicado: (2021)